Anne Eder Named Director of CBER’s OBRR

January 05, 2024

AABB congratulates Anne Eder, MD, PhD, who has been selected as the permanent director of the Office of Blood Research and Review (OBRR) in FDA’s Center for Biologics Evaluation and Research (CBER). Eder most recently served as the acting office director of OBRR and has been the deputy office director of OBRR since 2019. She joined FDA in 2016 as associate deputy division director, Division of Emerging and Transfusion Transmitted Diseases, in OBRR. She succeeds Nicole Verdun, MD, who became director of CBER’s Office of Therapeutic Products in July.